Dirk Thye

Insider Reports History

Location
San Diego, CA
Signature
/s/ Brendan Hannah as attorney-in-fact for Dirk Thye
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dirk Thye:

Company Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. CEO and CMO, Director Common Shares 739,885 $1,243,006 $1.68 10 Dec 2025 Thye Trust
Quince Therapeutics, Inc. CEO and CMO, Director Common Shares 255,000 $428,400 $1.68 10 Dec 2025 Direct
Quince Therapeutics, Inc. CEO and CMO, Director Warrants 150,944 $18,868 $0.1250 18 Jun 2025 Direct
Quince Therapeutics, Inc. CEO and CMO, Director Employee Stock Option (right to buy) 1,200,000 28 Jan 2025 Direct

Insider Reports Filed by Dirk Thye

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QNCX Quince Therapeutics, Inc. 10 Dec 2025 2 $0 4 CEO and CMO, Director 12 Dec 2025, 17:07
QNCX Quince Therapeutics, Inc. 18 Jun 2025 2 +$200,001 4 CEO and CMO, Director 23 Jun 2025, 08:43
QNCX Quince Therapeutics, Inc. 28 Jan 2025 1 $0 4 CEO AND CHIEF MEDICAL OFFICER, Director 11 Feb 2025, 17:44
QNCX Quince Therapeutics, Inc. 29 Aug 2024 2 +$107,375 4 CEO AND CHIEF MEDICAL OFFICER, Director 03 Sep 2024, 17:38
QNCX Quince Therapeutics, Inc. 01 Feb 2024 1 $0 4 CEO AND CHIEF MEDICAL OFFICER, Director 02 Feb 2024, 17:50
QNCX Quince Therapeutics, Inc. 16 Jan 2024 4 +$190,791 4 CHIEF EXECUTIVE OFFICER, Director 17 Jan 2024, 16:48
QNCX Quince Therapeutics, Inc. 10 Aug 2023 1 +$110,880 4 Chief Executive Officer, Director 11 Aug 2023, 16:15
QNCX Quince Therapeutics, Inc. 08 Aug 2023 1 +$99,200 4 Chief Executive Officer, Director 09 Aug 2023, 18:23
QNCX Quince Therapeutics, Inc. 01 Feb 2023 1 $0 4 Chief Executive Officer, Director 02 Feb 2023, 17:37
QNCX Cortexyme, Inc. 19 May 2022 1 $0 4/A Chief Executive Officer, Director 27 May 2022, 17:35
QNCX Cortexyme, Inc. 19 May 2022 0 $0 3 Chief Executive Officer, Director 23 May 2022, 20:26